Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

This study has been completed.
Sponsor:
Collaborators:
Innovative Medicines Initiative
GlaxoSmithKline
Sanofi Pasteur, a Sanofi Company
Information provided by (Responsible Party):
University of Surrey
ClinicalTrials.gov Identifier:
NCT01765413
First received: November 15, 2012
Last updated: May 7, 2014
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)